Get started
Work

P-020 Dendritic cell/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant (HCT) results in long-term sustained T cell activation and clonotypic expansion

Year: 2023
Type: conference-abstract
DOI: 10.1016/s2152-2650(23)01638-5
Authors: Dimitra Karagkouni, Giulia Cheloni, Daniela Torres, David Chung, Nina Shah, Natalie Callander, Thinle Chodon, Yvonne Efebera, Nancy Geller, Peiman Hematti, Hillard Lazarus, Ehsan Malek, Philip McCarthy, Ajay Nooka, Jacalyn Rosenblatt, Aaron Rapoport, Robert Soiffer, Lina Bisharat, Dina Stroopinsky, Edmund Waller, Marcelo Pasquini, Ioannis Vlachos, David Avigan
Institutions: Broad Institute, Beth Israel Deaconess Medical Center, Harvard University, University of Ostrava, University Hospital Ostrava, Alfred Health, Monash University, City Of Hope National Medical Center, City of Hope
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4387004089
Cites:
Cited by:
Related to: 10